Cbeyond (Nasdaq: CBEY) reported earnings on Aug. 2. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), Cbeyond beat slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share expanded. The profit was a surprise, as analysts had predicted a loss.

Margins improved across the board.

Revenue details
Cbeyond booked revenue of $123.8 million. The nine analysts polled by S&P Capital IQ expected to see sales of $122.4 million on the same basis. GAAP reported sales were 2.6% higher than the prior-year quarter's $120.6 million.

My

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.09. The eight earnings estimates compiled by S&P Capital IQ predicted -$0.02 per share. GAAP EPS were $0.09 for Q2 against -$0.06 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 67.5%, 80 basis points better than the prior-year quarter. Operating margin was 4.8%, 600 basis points better than the prior-year quarter. Net margin was 2.2%, 360 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $121.6 million. On the bottom line, the average EPS estimate is -$0.01.

Next year's average estimate for revenue is $490.2 million. The average EPS estimate is $0.02.

Investor sentiment
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 102 members out of 132 rating the stock outperform, and 30 members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Cbeyond a green thumbs-up, and 13 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cbeyond is hold, with an average price target of $9.79.